6TUX

human XPG-DNA, Complex 2

6TUX の概要

• エントリーDOI: 10.2210/pdb6tux/pdb
• 分子名称: DNA repair protein complementing XP-G cells,DNA repair protein complementing XP-G cells, DNA (5'-D(P*GP*CP*AP*GP*AP*GP*TP*T)-3'), DNA (5'-D(P*AP*AP*CP*TP*CP*TP*GP*C)-3') (3 entities in total)
• 機能のキーワード: xpg nuclease domain bound to dna, dna binding protein
• 由来する生物種: Homo sapiens (Human); 詳細
• タンパク質・核酸の鎖数: 6
• 化学式量合計: 94053.63

構造登録者

Ruiz, F.M.,Fernandez-Tornero, C. (登録日: 2020-01-08, 公開日: 2020-09-16, 最終更新日: 2024-01-24)

主引用文献

Gonzalez-Corrochano, R.,Ruiz, F.M.,Taylor, N.M.I.,Huecas, S.,Drakulic, S.,Spinola-Amilibia, M.,Fernandez-Tornero, C.
The crystal structure of human XPG, the xeroderma pigmentosum group G endonuclease, provides insight into nucleotide excision DNA repair.
Nucleic Acids Res., 48:9943-9958, 2020

PubMed Abstract: Nucleotide excision repair (NER) is an essential pathway to remove bulky lesions affecting one strand of DNA. Defects in components of this repair system are at the ground of genetic diseases such as xeroderma pigmentosum (XP) and Cockayne syndrome (CS). The XP complementation group G (XPG) endonuclease cleaves the damaged DNA strand on the 3' side of the lesion coordinated with DNA re-synthesis. Here, we determined crystal structures of the XPG nuclease domain in the absence and presence of DNA. The overall fold exhibits similarities to other flap endonucleases but XPG harbors a dynamic helical arch that is uniquely oriented and defines a gateway. DNA binding through a helix-2-turn-helix motif, assisted by one flanking α-helix on each side, shows high plasticity, which is likely relevant for DNA scanning. A positively-charged canyon defined by the hydrophobic wedge and β-pin motifs provides an additional DNA-binding surface. Mutational analysis identifies helical arch residues that play critical roles in XPG function. A model for XPG participation in NER is proposed. Our structures and biochemical data represent a valuable tool to understand the atomic ground of XP and CS, and constitute a starting point for potential therapeutic applications.

PubMed: 32821917
DOI: 10.1093/nar/gkaa688

実験手法

X-RAY DIFFRACTION (3.1 Å)